The taskforce is coordinating the worldwide pharma activities in the ATC global organization. On regional levels the country managers and their pharma experts on site are responsible for the local contacts and the implementation of the respective solutions
It is expected that the main origins for production will be in Europe, India, Brazil, Korea, China and the USA.
Together with their airline partners, the GSSA controls 300.000 tons of annual capacity and serves more than 500 destinations globally.
Furthermore ATC outlines any solution using charter capacities on Freighters and Preighters.
Ingo Zimmer, Group CEO ATC Aviation Services stated “We are well aware about the importance of our role in the supply chain of the vaccines and we are ready!”
